NeuroSense Therapeutics Ltd.
NRSN
$1.04
$0.05785.90%
NASDAQ
| 12/31/2023 | 12/31/2023 | 09/30/2023 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -44.53% | -44.53% | -32.87% | ||
| Total Receivables | -46.28% | -46.28% | -28.80% | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | -- | -- | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | 8.11% | 8.11% | -2.63% | ||
| Total Current Assets | -42.88% | -42.88% | -32.48% | ||
|
|
|||||
| Total Current Assets | -42.88% | -42.88% | -32.48% | ||
| Net Property, Plant & Equipment | -5.00% | -5.00% | -8.45% | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 4.76% | 4.76% | -8.70% | ||
| Total Assets | -40.87% | -40.87% | -31.55% | ||
|
|
|||||
| Total Accounts Payable | 59.80% | 59.80% | -16.24% | ||
| Total Accrued Expenses | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | -- | -- | -- | ||
| Total Finance Division Other Current Liabilities | -- | -- | -0.99% | ||
| Total Other Current Liabilities | -- | -- | -0.99% | ||
| Total Current Liabilities | 23.14% | 23.14% | -6.52% | ||
|
|
|||||
| Total Current Liabilities | 23.14% | 23.14% | -6.52% | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | -13.10% | -13.10% | -19.23% | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -47.49% | -47.49% | -57.34% | ||
| Total Liabilities | -11.43% | -11.43% | -40.70% | ||
|
|
|||||
| Common Stock & APIC | -15.76% | -15.76% | 1.99% | ||
| Retained Earnings | 10.29% | 10.29% | 2.62% | ||
| Treasury Stock & Other | -- | -- | -- | ||
| Total Common Equity | -797.45% | -797.45% | 87.31% | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | -- | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
|
|
|||||
| Total Common Equity | -797.45% | -797.45% | 87.31% | ||
| Total Preferred Equity | -- | -- | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | -797.45% | -797.45% | 87.31% | ||
|
|
|||||